The Retreat of the Amateur Investors (WSJ)
A pandemic boom attracted scores of Americans seeking gains. Now that some are backing away, the markets risk losing a key...
Society Pass (SOPA) $1.15 Breaks Above First Line of Resistance.
If you're familiar with the term, "..the stars are aligning" here is a real life example. If you're familiar with the term,...
Initiating Coverage on Society Pass (SOPA).
Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley
Society Pass (SOPA) Research Reports
RESEARCH REPORT ARCHIVE
December 27th, 2023. Litchfield Hills Research - $4.00 Price Target.
Adding Society Pass (SOPA) $0.96 to the Watch List
Amazing Fast Grower, in the Asian Silicon Valley.
After a wildly successful IPO debut and subsequent tumble, Society...
Smart for Life (SMFL) Announces Launch of Greens First Protein Bars.
New Line of Protein Bars Specifically Formulated with the Greens First PRO Line, Provides a Nutrient Dense Meal Replacement with 54 Super...
Smart for Life (SMFL) Announces 59% Increase in Revenues, Year-Over-Year
New Report Coming, Sign up to our Newsletter for Priority Notification.
Absolutely banging numbers, we view Smart...
Smart for Life (SMFL) Reports, Headlines and More.
Smart For Life Corporate Investor Center
2022, 28-11. ($0.40) Smart for Life (SMFL) Announces...
Progressive Care (RXMD) Conference Call.
Progressive Care Announces Shareholder Conference Call and Business Update on November 14, 2022
MIAMI, FL, Nov. 08, 2022...
DCS (DCSX) and Cellcom Enhance Partnership for IoT Solutions
LIVE QUOTE
San Diego, California--(Newsfile Corp. - November 14, 2022) - Direct Communication Solutions,...
Latest article
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
